Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis

AIMS: In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calcium-based phosphate binders (CB). However, their use is associated with vascular calcification and an increased mortality risk. The aim of this study was to assess the incremental cost-effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gros, Blanca, Galán, Antonio, González-Parra, Emilio, Herrero, Jose A, Echave, Maria, Vegter, Stefan, Tolley, Keith, Oyagüez, Itziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467815/
https://www.ncbi.nlm.nih.gov/pubmed/26062537
http://dx.doi.org/10.1186/s13561-015-0049-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467815/
https://www.ncbi.nlm.nih.gov/pubmed/26062537
http://dx.doi.org/10.1186/s13561-015-0049-3

Ejemplares similares